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Background
Hypertension (HTN) is a major worldwide cause of
stroke, heart failure, myocardial infarction, and chronic
kidney disease. Human genetics offers the potential to
identify novel physiologic mechanisms that underlie
blood pressure (BP). BP is a heritable trait but until
recently genetic factors that influence BP at the popula-
tion have been difficult to identify.
Results
We used a candidate gene association study of common
variants across the NPPA-NPPB locus to identify genetic
variants that influence atrial natriuretic peptide (ANP)
and B-type natriuretic peptide (BNP) [1]. The minor
alleles of three noncoding SNPs rs5068 (MAF 0.06),
rs198358 (MAF 0.19) and rs632793 (MAF 0.38) were
associated with higher ANP (+0.42 SD p=8x10-70; +0.20
p=8x10-30; +0.08 p=2x10-10, respectively) and higher
BNP (+0.17 SD p=3x10-12, +0.18 p=9x10-25, +0.21
p=2x10-68) in 14,515 individuals of European ancestry.
The alleles of rs5068 and rs198358 associated with
higher ANP/BNP were associated with lower SBP
(p=2x10-6, p=6x10-5, respectively) and lower DBP
(p=1x10-6, p=5x10-5) as well as lower odds of HTN
(OR 0.85 p=4x10-5, OR 0.90 p=2x10-4) in 29,717 indivi-
duals. The association of rs5068 was replicated in the
Global BPgen GWAS [2]. Recently, Kato et al reported
the association of a common variant downstream of
NPR3 encoding the natriuretic peptide clearance recep-
tor [3]. Murine NPR3 knockout is associated with lower
BP, consistent with higher levels of circulating natriure-
tic peptides [4]. The minor allele of a SNP highly corre-
lated to the BP NPR3 SNP has recently been reported to
be associated with taller stature in humans [5],
consistent with the effect of murine knockout [4] or
apparent loss-of-function mutations [6] in NPR3.
Conclusion
The ANP-BNP/pGC/cGMP axis is important in the reg-
ulation of BP in humans. Further ongoing GWAS stu-
dies have identified additional novel loci. Human
genetics can offer an entrée into the physiologic deter-
minants of blood pressure at the population level and
point to therapeutic opportunities to reduce the morbid-
ity and mortality due to HTN.
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